Results
183
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
183 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$31.63 | -1.0% | 92.9% | US$5.2b | US$29.42 | PS27.1x | E60.9% | n/a | Semiconductors | ||
EH | US$14.59 | 7.4% | -6.5% | US$923.3m | US$24.98 | PS42.8x | E74.3% | n/a | Capital Goods | ||
ATAT | US$18.64 | 1.6% | 7.4% | US$2.6b | US$27.17 | PE19.1x | E22.1% | 0.8% | Consumer Services | ||
TBBB | US$23.72 | -0.6% | n/a | US$2.7b | US$26.84 | PS1x | E94.7% | n/a | Consumer Retailing | ||
GCT | US$32.19 | 5.8% | 351.5% | US$1.3b | US$52.33 | PE12.5x | E21.3% | n/a | Retail | ||
PDD | US$136.19 | 2.4% | 94.6% | US$189.1b | US$205.58 | PE17.2x | E23.3% | n/a | Retail | ||
CG | US$40.29 | 0.3% | 27.0% | US$14.5b | US$48.45 | PS6.5x | E23.6% | 3.5% | Diversified Financials | ||
SMCI | US$846.58 | 3.3% | 225.6% | US$49.6b | US$1,032.47 | PE47.3x | E40.2% | n/a | Tech | ||
BRDG | US$7.32 | -1.3% | -38.4% | US$885.6m | US$9.88 | PB3.4x | E98.2% | 9.0% | Diversified Financials | ||
DUOL | US$193.09 | -7.5% | 42.8% | US$8.3b | US$252.23 | PE182.6x | E48.1% | n/a | Consumer Services | ||
MAX | US$12.51 | -5.0% | 29.8% | US$823.7m | US$25.33 | PS1.6x | E88.1% | n/a | Media | ||
ZKH | US$3.89 | -0.3% | n/a | US$626.6m | US$15.74 | PB1.4x | E104.4% | n/a | Capital Goods | ||
HOFV | US$2.90 | 0.7% | -67.5% | US$18.9m | US$8.00 | PB0.2x | E71.1% | n/a | Consumer Services | ||
MDGL | US$276.55 | -1.3% | 26.2% | US$5.9b | US$365.07 | PB6.9x | E63.8% | n/a | Pharmaceuticals & Biotech | ||
HSAI | US$4.35 | 3.8% | -58.7% | US$554.5m | US$10.07 | PS2.2x | E71.0% | n/a | Automobiles | ||
ESTA | US$43.23 | -4.9% | -32.1% | US$1.2b | US$65.14 | PS7.6x | E68.2% | n/a | Healthcare | ||
RYAN | US$57.98 | 0.1% | 28.5% | US$15.1b | US$58.08 | PE108.5x | E56.6% | 0.8% | Insurance | ||
CARG | US$24.93 | -4.8% | 13.0% | US$2.6b | US$26.85 | PE71.6x | E30.0% | n/a | Media | ||
HSCS | US$4.41 | -15.4% | -95.0% | US$2.9m | US$67.50 | PS155.4x | E66.8% | n/a | Healthcare | ||
MYO | US$2.87 | -10.6% | 275.2% | US$82.7m | US$6.60 | PS4.2x | E66.0% | n/a | Healthcare | ||
HNVR | US$16.06 | -2.7% | -12.2% | US$116.4m | US$18.50 | PB0.6x | E20.9% | 2.5% | Banks | ||
EVOK | US$0.54 | 2.1% | -68.2% | US$4.6m | US$7.00 | PB1.3x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
SPRY | US$9.10 | 6.9% | 48.5% | US$881.7m | US$19.00 | PS88174.7x | E57.7% | n/a | Pharmaceuticals & Biotech | ||
SPOT | US$316.85 | 1.0% | 101.9% | US$63.1b | US$346.34 | PS4.2x | E40.6% | n/a | Media |